Translumina Therapeutics

Translumina Therapeutics

Signal active

Organization

Contact Information

Overview

Translumina Therapeutics is a maker of cutting-edge cardiovascular medical devices. Translumina Therapeutics offers a diverse portfolio of innovative quality products at reasonable prices to help improve clinical outcomes. Translumina Therapeutics collaborates with world-class hospitals, engineering institutes, global technology firms, and renowned interventional cardiologists.

About

Industries

Marketing, Manufacturing, Medical Device

Founded

2010

Employees

251-500

Headquarters locations

India, Asia

Social

N/A

Profile Resume

Translumina Therapeutics headquartered in India, Asia, operates in the Marketing, Manufacturing, Medical Device sector. The company focuses on Marketing and has secured $838.6M in funding across 12 round(s). With a team of 251-500 employees, Translumina Therapeutics is actively contributing to advancements in Marketing. Their latest funding round, Private Equity Round - Translumina Therapeutics, raised $69.9M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Punita Arora

Punita Arora

Co-Founder, Managing Partner and Board Member

imagePlace Gurmit Singh Chugh

Gurmit Singh Chugh

Managing Director

imagePlace Paritosh Arora

Paritosh Arora

Chief Commercial Officer

imagePlace Kewal Krishan

Kewal Krishan

Chief Financial Officer

Funding Rounds

Funding rounds

1

Investors

1

Lead Investors

0

Total Funding Amount

$69.9M

Details

1

Translumina Therapeutics has raised a total of $69.9M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Private Equity69.9M

Investors

Translumina Therapeutics is funded by 3 investors.

Investor NameLead InvestorFunding RoundPartners
Arjun Oberoi-FUNDING ROUND - Arjun Oberoi69.9M
Translumina Therapeutics-FUNDING ROUND - Translumina Therapeutics69.9M
Everstone-FUNDING ROUND - Everstone69.9M

Recent Activity

There is no recent news or activity for this profile.